494429
Dimethyl sulfoxide
biotech. grade, 99.8%
Synonym(s):
DMSO
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
(CH3)2SO
CAS Number:
Molecular Weight:
78.13
EC Number:
200-664-3
UNSPSC Code:
12191502
PubChem Substance ID:
Beilstein/REAXYS Number:
506008
MDL number:
grade
biotech. grade
vapor density
2.7 (vs air)
vapor pressure
0.42 mmHg ( 20 °C)
assay
99.8%
autoignition temp.
573 °F
expl. lim.
42 %, 63 °F
impurities
<0.005% water
evapn. residue
<0.0005%
refractive index
n20/D 1.479 (lit.)
bp
189 °C (lit.)
mp
16-19 °C (lit.)
density
1.10 g/mL (lit.)
λ
H2O reference
UV absorption
λ: 270 nm Amax: 1.00, λ: 280 nm Amax: 0.30, λ: 295 nm Amax: 0.10, λ: 350-400 nm Amax: 0.01
SMILES string
CS(C)=O
InChI
1S/C2H6OS/c1-4(2)3/h1-2H3
InChI key
IAZDPXIOMUYVGZ-UHFFFAOYSA-N
Packaging
Disclaimer
Supercools easily and remelts slowly at room temperature. Solidified product can be re-liquified by warming to room temperature without detriment to the product.
Still not finding the right product?
Explore all of our products under Dimethyl sulfoxide
Storage Class
10 - Combustible liquids
wgk
WGK 1
flash_point_f
188.6 °F - closed cup
flash_point_c
87 °C - closed cup
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Claudia C Faria et al.
Cancer research, 75(1), 134-146 (2014-11-14)
Medulloblastoma is the most common malignant pediatric brain tumor, with metastases present at diagnosis conferring a poor prognosis. Mechanisms of dissemination are poorly understood and metastatic lesions are genetically divergent from the matched primary tumor. Effective and less toxic therapies
Phillip McDonagh et al.
Veterinary microbiology, 174(3-4), 438-447 (2014-12-04)
Feline infectious peritonitis (FIP), a feline coronavirus (FCoV) induced disease, is almost invariably fatal with median life expectancy measured in days. Current treatment options are, at best, palliative. The objectives of this study were to evaluate a panel of nineteen
A Hillarp et al.
Journal of thrombosis and haemostasis : JTH, 12(9), 1545-1553 (2014-06-27)
Apixaban is an oral direct factor Xa inhibitor developed for the prophylaxis and treatment of thromboembolic disorders. Laboratory monitoring is not necessary, but the effects on common coagulation reagents and assays constitute clinically valuable information. To investigate the effects of apixaban